Computer-Aided Drug Design in Modern Drug Discovery offers an in-depth exploration of CADD, featuring real-world case studies and practical examples that empower researchers to effectively harness this technology in drug discovery and development. Exploring the intricacies of CADD, the book comprises several key chapters, beginning with an introduction to its methods and evolution that is followed by a thorough examination of the integration of artificial intelligence in drug design. Subsequent chapters cover various CADD approaches, including ligand-based, structure-based, and fragment-based design, alongside AI-driven compound generation and drug screening.
The book also showcases a selection of marketed drugs developed with CADD or AI, such as Captopril, Tirofiban, and Crizotinib, providing invaluable insights into the successes and challenges faced in real-world applications. Finally, the discussion of emerging trends and future directions in CADD and AI highlights the ongoing evolution of these methodologies and their integration with traditional drug development processes.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr. Yinuo Wu is an associate Professor in Medicinal Chemistry. She did her undergraduate degree at the Sun Yat-sen University (2002-2006) and then carried out a PhD (2006-2011). After two years of post-doctoral at the Hong Kong polytechnic University, she started her academic career in 2013 at Sun Yat-sen University. Dr. Yinuo Wu is particularly interested in the development of anti-fibrosis drug candidates. In the last five years, Dr. Wu has more than 50 publications and several patents on this field.
Dr. Tianmiao Ou is a Professor in Medicinal Chemistry and Chemical Biology. She did her undergraduate degree at the China Pharmaceutical University (1998-2002) and then carried out a PhD under the supervision of Professor Lianquan Gu (2002-2007). She started her academic career in 2007 in the Sun Yat-sen University. She had traveled to UK as an academic visitor and worked in the group of Professor Shankar Balasubramanian at the University of Cambridge (2012-2013). The whole group is particularly interested in the role of non-canonical nucleic acid structures that control gene expression (e.g. G-quadruplexes, and RNA structures in the non-coding regions of mRNAs). Their goal is to find out small organic molecules that target such structures and alter the expression of certain genes of interest. Such small molecule gene regulators are valuable tools to study mechanisms in biology and will also open up new approaches for therapeutics and molecular medicine, particularly for diseases characterized by aberrant expression of certain genes. Under the support of various funding, Dr. Ou has more than 70 publications and several patents on this field.
Computer-Aided Drug Design (CADD) is a key technology in pharmacology, significantly influencing the development of numerous marketed drugs. Despite the wealth of theoretical literature on CADD, there remains a critical gap in resources that illustrate its practical applications. Computer-Aided Drug Design in Modern Drug Discovery bridges that gap by offering an in-depth exploration of CADD, featuring real-world case studies and practical examples that empower researchers to harness this technology effectively in drug discovery and development. Exploring the intricacies of CADD, the book comprises several key chapters, beginning with an introduction to its methods and evolution, followed by a thorough examination of the integration of artificial intelligence in drug design. Subsequent chapters cover various CADD approaches, including ligand-based, structure-based, and fragment-based design, alongside AI-driven compound generation and drug screening. The book also showcases a selection of marketed drugs developed with CADD or AI, such as Captopril, Tirofiban, and Crizotinib, providing invaluable insights into the successes and challenges faced in real-world applications. Finally, the discussion of emerging trends and future directions in CADD and AI highlights the ongoing evolution of these methodologies and their integration with traditional drug development processes. By emphasizing accessible language and practical applications, this book serves as an essential resource for pharmacology researchers, practitioners, and students alike, enabling them to navigate the complexities of drug design with confidence. Medicinal chemists will also benefit from this comprehensive guide to enhance your understanding of CADD and inspire innovative approaches to drug discovery and development.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Artikel-Nr. 408815839
Anzahl: 3 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. 450 pages. 7.52x0.73x9.25 inches. In Stock. Artikel-Nr. __0443451052
Anzahl: 2 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Provides real-world case studies that demonstrate successful CADD applications in drug developmentSimplifies complex concepts, making CADD accessible for researchers at all experience levelsHighlights emerging trends and future dir. Artikel-Nr. 2726780722
Anzahl: 3 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. 450 pages. 7.52x0.73x9.25 inches. In Stock. Artikel-Nr. x-0443451052
Anzahl: 2 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. 2026. paperback. . . . . . Books ship from the US and Ireland. Artikel-Nr. V9780443451058
Anzahl: Mehr als 20 verfügbar